Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

BACKGROUND: Health related quality of life (HRQOL) is an important outcome after treatment for upper gastrointestinal carcinoma. This study aimed to compare HRQOL in patients with advanced gastric cancer (GC) receiving either a standard or an experimental treatment. METHODS: Seventy-one patients hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadighi, Sanambar, Mohagheghi, Mohammad Ali, Montazeri, Ali, Sadighi, Zahra
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693922/
https://www.ncbi.nlm.nih.gov/pubmed/17147808
http://dx.doi.org/10.1186/1471-2407-6-274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693922/
https://www.ncbi.nlm.nih.gov/pubmed/17147808
http://dx.doi.org/10.1186/1471-2407-6-274

Ejemplares similares